Sinossi
The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Contenuti
High-Risk Breast Cancer: Definition of the Risk.- Epidemiology.- Breast Cancer Risk and Chemoprevention.- Oncogenes.- Genetic Aspects of Human Breast Cancer.- Significance of Oncogenes in Breast Cancer: Review.- Flow Cytometry.- Measurement of DNA Content of Archival Material as a Guide to Prognosis.- Flow Cytometry in the Management of Breast Cancer.- The Role of Fine-Needle Aspiration in Determining the Risk of Breast Cancer.- Tumor Kinetics.- Measurements of Cellular Proliferation and DNA in Breast Carcinoma.- Tumor Kinetics in Experimental Mammary Carcinoma.- Receptors.- Hormone Receptors and Risk in Breast Cancer.- Overview of the Prognostic and Clinical Correlates of Steroid Hormone Receptors in Human Breast Cancer.- Pathology.- Identification of Risk Factors by Conventional Pathologic and Some Ancillary Techniques in Women with Breast Cancer.- Mammography.- The Role of Mammographic Screening in the Control of Breast Cancer: An Overview.- The Role of Screening Mammography in Determining Risk in Breast Lesions.- Immunology.- The Role of Monoclonal and Polyclonal Antibodies in Assessing Risk in Breast Cancer.- A Review of the Role of Immune Reactants in Patients with High-Risk Breast Carcinoma.- General.- Growth Regulation of Breast Cancer.- In Vitro Predictive Sensitivity Testing in the Therapeutic Assessment of Breast Cancer.- The Role of Chromosome Analysis in the Investigation of Breast Cancer.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Altre edizioni note dello stesso titolo
Risultati della ricerca per High-Risk Breast Cancer: Diagnosis
Foto dell'editore
High-Risk Breast Cancer (eng)
Print on DemandDa: Brook Bookstore On Demand, Napoli, NA, Italia
Valutazione del venditore 3 su 5 stelle
Condizione: new. Questo è un articolo print on demand. Codice articolo U32DCDOF85
Compra nuovo
EUR 86,24
Spedizione EUR 6,80
Spedito da Italia a U.S.A.
Spedito da Italia a U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
High-Risk Breast Cancer: Diagnosis
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
Condizione: New. In. Codice articolo ria9783642737206_new
Compra nuovo
EUR 115,35
Spedizione EUR 13,85
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
High-Risk Breast Cancer
Editore:
Springer, Springer Dez 2011, 2011
ISBN 10: 364273720X
ISBN 13: 9783642737206
Nuovo
Taschenbuch
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers. 400 pp. Englisch. Codice articolo 9783642737206
Compra nuovo
EUR 106,99
Spedizione EUR 23,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 2 disponibili
Immagini fornite dal venditore
High-Risk Breast Cancer
Print on DemandDa: moluna, Greven, Germania
Valutazione del venditore 5 su 5 stelle
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate l. Codice articolo 5069364
Compra nuovo
EUR 92,27
Spedizione EUR 48,99
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
High-Risk Breast Cancer
Editore:
Springer, Springer Dez 2011, 2011
ISBN 10: 364273720X
ISBN 13: 9783642737206
Nuovo
Taschenbuch
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 400 pp. Englisch. Codice articolo 9783642737206
Compra nuovo
EUR 106,99
Spedizione EUR 60,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili
Foto dell'editore
High-Risk Breast Cancer
Da: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. pp. xi + 383. Codice articolo 2658580081
Compra nuovo
EUR 164,51
Spedizione EUR 3,44
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: 4 disponibili
Foto dell'editore
High-Risk Breast Cancer: Diagnosis
Da: Revaluation Books, Exeter, Regno Unito
Valutazione del venditore 5 su 5 stelle
Paperback. Condizione: Brand New. reprint edition. 394 pages. 9.40x6.10x0.90 inches. In Stock. Codice articolo x-364273720X
Compra nuovo
EUR 154,72
Spedizione EUR 14,45
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: 2 disponibili
Immagini fornite dal venditore
High-Risk Breast Cancer : Diagnosis
Editore:
Springer Berlin Heidelberg, 2011
ISBN 10: 364273720X
ISBN 13: 9783642737206
Nuovo
Taschenbuch
Da: AHA-BUCH GmbH, Einbeck, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers. Codice articolo 9783642737206
Compra nuovo
EUR 106,99
Spedizione EUR 63,41
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili
Foto dell'editore
High-Risk Breast Cancer
Print on DemandDa: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
Condizione: New. Print on Demand pp. xi + 383 67 Figures. Codice articolo 51012526
Compra nuovo
EUR 168,72
Spedizione EUR 7,51
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: 4 disponibili
Foto dell'editore
High-Risk Breast Cancer
Print on DemandDa: Biblios, Frankfurt am main, HESSE, Germania
Valutazione del venditore 4 su 5 stelle
Condizione: New. PRINT ON DEMAND pp. xi + 383. Codice articolo 1858580091
Compra nuovo
EUR 169,59
Spedizione EUR 9,95
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 4 disponibili